Diagnostics

Hybrid Silica Technologies, located in Cambridge, MA, is a company recognized for its commitment to quality, having achieved ISO 9001 certification since 1994, and ISO 14001 certification in 2002. The organization specializes in developing advanced silica solutions tailored for various industrial applications, showcasing a dedication to innovation and sustainability. The company's consistent adherence to rigorous international standards reflects its focus on operational excellence and environmental responsibility. With a rich history dating back to its founding, Hybrid Silica Technologies continues to push boundaries in the silica technology landscape. Generated from the website

Vedanta Biosciences, Inc., based in Cambridge, MA, is at the forefront of developing first-in-class Live Biotherapeutic Products (LBPs) to address serious gastrointestinal diseases through the strategic use of defined bacterial consortia. The company is focused on advancing innovative treatments for conditions such as inflammatory bowel disease and recurrent Clostridium difficile infections, with ongoing clinical trials to evaluate the efficacy and safety of its drug candidates. Committed to improving patient outcomes, Vedanta emphasizes the importance of gut health and the role of dysbiosis in gastrointestinal disorders. Through a robust scientific framework, the company leverages its expertise in immune response stimulation and microbial therapies to usher in a new era of gastrointestinal health management. Generated from the website

Genewiz, a division of Azenta Life Sciences, offers a wide array of advanced genetic analysis services including Next Generation Sequencing, Sanger Sequencing, and RNA synthesis. Their expertise spans various research areas such as cancer research, genomics, agricultural sciences, and synthetic biology, catering to diverse scientific needs. Known for its commitment to quality and compliance, Genewiz also provides GLP-compliant services along with clinical solutions to support the evolving demands of the life sciences industry. With new offerings like Single Cell Sequencing and Immunogenomics, the company continues to push the boundaries of genetic research and innovation. Generated from the website